Health

Novartis Venture Fund returned as GentiBio raised money that will support the progress of its type 1 diabetes drug candidate toward clinical trials.

Oxford Sciences Innovation returned to reinvest in the smart echocardiogram technology spinout, helping increase its overall funding to nearly $60m.

Blue Venture Fund led a round that included corporate venturing units GV and Optum Ventures, taking the medical imaging system developer's total funding to almost $60m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ventricular assistance system developer CH Biomedical closed a Baheal-backed series D round while peer-to-peer lending platform Alami secured $17.5m in a round led by EV Growth.

Early backers including Micromax Informatics are receiving 15-times returns on their investment in the health management app developer.

A Hanwha subsidiary will take an 8.8% stake in the UK-based satellite connectivity provider OneWeb, helping it increase its funding to $2.7bn since it has resurrected from bankruptcy.

TU Delft and UMC Utrecht spinout MILabs has been purchased by Rigaku Corporation, which plans to use its medical imaging technology in drug development.

SoftBank Ventures Asia led ERP software provider Mabang's $46.3m series B round while Mainport Innovation Fund exited electrification technology developer ViriCiti.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sino Biopharmaceutical was among the participants in a round valuing the drug development technology provider at over $2bn.